Only biotechwith 2 Myron'son theleadershipteamWe intendto submita BLA in2H 2022Our Halo-Lido trial willhave finalpatient byend of 2022An actualiMSCupdateNot manycompaniesthis size with2 late stageassetsMino-Lokis our leadassetMino-WrapI'm ashareholdermyselfWe will openupinternationalsites forMino-Lok trialThe name Citiuscomes from theOlympic motto"Citius,AltiusFortius"Myron Holubiakand I founded aprivatecompany in2013Mino-Lokpotentialmarket>$1BHemorrhoidsis a $2BmarketWe expect tofinish theMino-Loktrial this yearInsidersinvested$26.5mI/ONTAKis our leadassetWe had aphase 2btrial with100%efficacyWe haveenough cashto go wellinto 2023I/ONTAK'spotentialmarket is>$300mI won't diluteshareholdersWe willhaveexclusivityI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.I/ONTAKwas thebest deal Iever madeThere are noFDAapproveddrugs to treathemorrhoidsOnly biotechwith 2 Myron'son theleadershipteamWe intendto submita BLA in2H 2022Our Halo-Lido trial willhave finalpatient byend of 2022An actualiMSCupdateNot manycompaniesthis size with2 late stageassetsMino-Lokis our leadassetMino-WrapI'm ashareholdermyselfWe will openupinternationalsites forMino-Lok trialThe name Citiuscomes from theOlympic motto"Citius,AltiusFortius"Myron Holubiakand I founded aprivatecompany in2013Mino-Lokpotentialmarket>$1BHemorrhoidsis a $2BmarketWe expect tofinish theMino-Loktrial this yearInsidersinvested$26.5mI/ONTAKis our leadassetWe had aphase 2btrial with100%efficacyWe haveenough cashto go wellinto 2023I/ONTAK'spotentialmarket is>$300mI won't diluteshareholdersWe willhaveexclusivityI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.I/ONTAKwas thebest deal Iever madeThere are noFDAapproveddrugs to treathemorrhoids

Leonard Mazur HCW Conference - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Only biotech with 2 Myron's on the leadership team
  2. We intend to submit a BLA in 2H 2022
  3. Our Halo-Lido trial will have final patient by end of 2022
  4. An actual iMSC update
  5. Not many companies this size with 2 late stage assets
  6. Mino-Lok is our lead asset
  7. Mino-Wrap
  8. I'm a shareholder myself
  9. We will open up international sites for Mino-Lok trial
  10. The name Citius comes from the Olympic motto "Citius,Altius Fortius"
  11. Myron Holubiak and I founded a private company in 2013
  12. Mino-Lok potential market >$1B
  13. Hemorrhoids is a $2B market
  14. We expect to finish the Mino-Lok trial this year
  15. Insiders invested $26.5m
  16. I/ONTAK is our lead asset
  17. We had a phase 2b trial with 100% efficacy
  18. We have enough cash to go well into 2023
  19. I/ONTAK's potential market is >$300m
  20. I won't dilute shareholders
  21. We will have exclusivity
  22. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  23. I/ONTAK was the best deal I ever made
  24. There are no FDA approved drugs to treat hemorrhoids